In recent years, the area of Medicine and Healthcare has made significant advances with the assistance of computational technology. During this time, new diagnostic techniques were developed. Cancer is the world's second-largest cause of mortality, claiming the lives of one out of every six individuals. The colon cancer variation is the most frequent and lethal of the numerous kinds of cancer. Identifying the illness at an early stage, on the other hand, substantially increases the odds of survival. A cancer diagnosis may be automated by using the power of Artificial Intelligence (AI), allowing us to evaluate more cases in less time and at a lower cost. In this research, CNN models are employed to analyse imaging data of colon cells. For colon cell image classification, CNN with max pooling and average pooling layers and MobileNetV2 models are utilized. To determine the learning rate, the models are trained and evaluated at various Epochs. It's found that the accuracy of the max pooling and average pooling layers is 97.49% and 95.48%, respectively. And MobileNetV2 outperforms the other two models with the most remarkable accuracy of 99.67% with a data loss rate of 1.24.

In recent years, lung disease has increased manyfold, causing millions of casualties annually. To combat the crisis, an efficient, reliable, and affordable lung disease diagnosis technique has become indispensable. In this study, a multiclass classification of lung disease from frontal chest X-ray imaging using a fine-tuned CNN model is proposed. The classification is conducted on 10 disease classes of the lungs, namely COVID-19, Effusion, Tuberculosis, Pneumonia, Lung Opacity, Mass, Nodule, Pneumothorax, and Pulmonary Fibrosis, along with the Normal class. The dataset is a collective dataset gathered from multiple sources. After pre-processing and balancing the dataset with eight augmentation techniques, a total of 80,000 X-ray images were fed to the model for classification purposes. Initially, eight pre-trained CNN models, AlexNet, GoogLeNet, InceptionV3, MobileNetV2, VGG16, ResNet 50, DenseNet121, and EfficientNetB7, were employed on the dataset. Among these, the VGG16 achieved the highest accuracy at 92.95%. To further improve the classification accuracy, LungNet22 was constructed upon the primary structure of the VGG16 model. An ablation study was used in the work to determine the different hyper-parameters. Using the Adam Optimizer, the proposed model achieved a commendable accuracy of 98.89%. To verify the performance of the model, several performance matrices, including the ROC curve and the AUC values, were computed as well.

Alzheimer's disease is largely the underlying cause of dementia due to its progressive neurodegenerative nature among the elderly. The disease can be divided into five stages: Subjective Memory Concern (SMC), Mild Cognitive Impairment (MCI), Early MCI (EMCI), Late MCI (LMCI), and Alzheimer's Disease (AD). Alzheimer's disease is conventionally diagnosed using an MRI scan of the brain. In this research, we propose a fine-tuned convolutional neural network (CNN) classifier called AlzheimerNet, which can identify all five stages of Alzheimer's disease and the Normal Control (NC) class. The ADNI database's MRI scan dataset is obtained for use in training and testing the proposed model. To prepare the raw data for analysis, we applied the CLAHE image enhancement method. Data augmentation was used to remedy the unbalanced nature of the dataset and the resultant dataset consisted of 60000 image data on the 6 classes. Initially, five existing models including VGG16, MobileNetV2, AlexNet, ResNet50 and InceptionV3 were trained and tested to achieve test accuracies of 78.84%, 86.85%, 78.87%, 80.98% and 96.31% respectively. Since InceptionV3 provides the highest accuracy, this model is later modified to design the AlzheimerNet using RMSprop optimizer and learning rate 0.00001 to achieve the highest test accuracy of 98.67%. The five pre-trained models and the proposed fine-tuned model were compared in terms of various performance matrices to demonstrate whether the AlzheimerNet model is in fact performing better in classifying and detecting the six classes. An ablation study shows the hyperparameters used in the experiment. The suggested model outperforms the traditional methods for classifying Alzheimer's disease stages from brain MRI, as measured by a two-tailed Wilcoxon signed-rank test, with a significance of < 0.05.

Chronic kidney disease (CKD) is one of the most life-threatening disorders. To improve survivability, early discovery and good management are encouraged. In this paper, CKD was diagnosed using multiple optimized neural networks against traditional neural networks on the UCI machine learning dataset, to identify the most efficient model for the task. The study works on the binary classification of CKD from 24 attributes. For classification, optimized CNN (OCNN), ANN (OANN), and LSTM (OLSTM) models were used as well as traditional CNN, ANN, and LSTM models. With various performance matrixes, error measures, loss values, AUC values, and compilation time, the implemented models are compared to identify the most competent model for the classification of CKD. It is observed that, overall, the optimized models have better performance compared to the traditional models. The highest validation accuracy among the tradition models were achieved from CNN with 92.71%, whereas OCNN, OANN, and OLSTM have higher accuracies of 98.75%, 96.25%, and 98.5%, respectively. Additionally, OCNN has the highest AUC score of 0.99 and the lowest compilation time for classification with 0.00447 s, making it the most efficient model for the diagnosis of CKD.

No abstract